Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function and impair hematopoietic differentiation - Figueroa, M E; Abdel-Wahab, O; Lu, C (Cancer Cell, 2010)
et al.